Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ofloxacin (0.3% w/v) Eye Ear Drops
Therapeutic Category
Antibiotic, General and OTC medicines, Ophthalmology, ENT
Dosage Form
Eye_Ear Drop
Packaging Type
Dropper
Packaging
10ml
Price
₹89/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ofloglee Eye/Ear Drop contains Ofloxacin (0.3% w/v), a broad-spectrum fluoroquinolone antibiotic used to treat bacterial infections of the eye and ear. It works by inhibiting bacterial DNA gyrase, effectively halting bacterial replication and eradicating infection. This formulation is specifically designed to provide targeted relief from conditions like conjunctivitis (pink eye), corneal ulcers, and ear infections such as otitis externa or otitis media.
The drop ensures rapid action and relief from symptoms such as redness, swelling, itching, and pain caused by bacterial infections. Ofloglee Eye/Ear Drop is highly effective against a wide range of bacteria, making it a trusted choice for managing ocular and otic bacterial infections. Its easy-to-use dropper packaging enhances convenience and ensures precise dosing for optimal therapeutic results.
Patients using this medication often experience quick improvement in symptoms, helping them resume normal activities without discomfort. The formulation is safe for use when applied as directed by a healthcare provider.
Common side effects may include temporary stinging or burning at the application site, itching, or dryness. Rarely, it may cause allergic reactions.
Used for bacterial eye infections (e.g., conjunctivitis, corneal ulcers) and ear infections (e.g., otitis externa, otitis media).
Use under medical supervision. Avoid touching the dropper tip to any surface to prevent contamination. Complete the full course of treatment as prescribed, even if symptoms improve.
Store in a cool, dry place below 25°C. Protect from direct light and heat. Keep the bottle tightly closed when not in use.
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v)
Composition : Tobramycin (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ofloxacin 0.3% w/v Eye & Ear Drops is a broad-spectrum fluoroquinolone antibiotic formulation used for the treatment of bacterial eye and ear infections such as conjunctivitis, blepharitis, keratitis, otitis externa, eye redness with infection, and ear discharge caused by susceptible bacteria. It works by inhibiting bacterial DNA replication, providing fast relief from infection. It is a valuable ENT and ophthalmology anti-infective segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from ophthalmologists, ENT specialists, general physicians, and clinics. Eye and ear infections are very common in all seasons, ensuring steady prescriptions, repeat demand, and strong retail movement across pharmacies.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the ophthalmic, ENT, and anti-infective segments with monopoly rights, quality manufacturing standards, promotional support, and reliable supply services for distributors and medical agencies.
Wholesalers and healthcare suppliers benefit from high prescription frequency in infection cases, strong demand from clinics and hospitals, seasonal spikes in eye infections, and continuous retail consumption, making it a stable and fast-moving pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in ophthalmic and ENT anti-infective formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the eye and ear infection management segment.